For the inhibition of ASM, we chose the drug amitriptyline, which is a tricyclic antidepressant often used in MM patients to treat side effects of neuropathy induced by either bortezomib or thalidomide treatment. Here, SMPD1 is linked to Miyoshi myopathy.